| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| flecainide acetate | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 25/07/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 25/07/2025 |
| medronic acid | Injection, powder for | 10 mg | Current | Unavailable | Manufacturing | 25/07/2025 |
| venlafaxine hydrochloride | Capsule, modified release | 169.71 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 25/07/2025 |
| doxorubicin hydrochloride | Injection, concentrated | 2 mg/mL | Current | Limited Availability | Manufacturing | 25/07/2025 |
| live varicella vaccine | Injection, powder for | 4000 PFU/mL | Current | Only available under NIP or government programs | Unexpected increase in demand due to other sponsors unable to supply | 25/07/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 25/07/2025 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Limited Availability | Manufacturing | 25/07/2025 |
| adrenaline (epinephrine) | Injection, solution | 500 microgram | Current | Unavailable | Manufacturing | 25/07/2025 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Anticipated | Available | Manufacturing | 25/07/2025 |
| avatrombopag maleate | Tablet, film coated | 23.6 mg | Current | Limited Availability | Manufacturing | 25/07/2025 |
| ramipril | Tablet, uncoated | 1.25 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 25/07/2025 |
| trandolapril | Capsule, hard | 2 mg | Current | Limited Availability | Manufacturing | 25/07/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 25/07/2025 |
| nizatidine | Capsule | 150 mg | Current | Limited Availability | Manufacturing | 25/07/2025 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 20.51 mg~16 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 25/07/2025 |
| dexamethasone~framycetin sulfate~gramicidin | Ear Drops | .5 mg/mL~5 mg/mL~.05 mg/mL | Current | Unavailable | Manufacturing | 24/07/2025 |
| mirtazapine | Tablet, film coated | 45 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| pioglitazone hydrochloride | Tablet | 16.63 mg | Anticipated | Available | Manufacturing | 24/07/2025 |
| ropivacaine hydrochloride | Injection, solution | 40 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 24/07/2025 |
| ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~41.583 mg | Current | Limited Availability | Manufacturing | 24/07/2025 |
| isotretinoin | Capsule, soft | 10 mg | Anticipated | Available | Manufacturing | 24/07/2025 |
| Influenza virus haemagglutinin | Injection, suspension | 15 microgram | Resolved | Available | Seasonal depletion of stock | 24/07/2025 |
| solifenacin succinate | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| lacosamide | Tablet, film coated | 200 mg | Current | Unavailable | Manufacturing | 24/07/2025 |
| larotrectinib sulfate | Capsule, hard | 30.7 mg | Current | Limited Availability | Unexpected increase in consumer demand | 24/07/2025 |
| rivaroxaban | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| oxaliplatin | Injection, concentrated | 100 mg | Current | Limited Availability | Manufacturing | 24/07/2025 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Resolved | Available | Manufacturing | 24/07/2025 |
| metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, modified release | 1000 mg~113.37 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, modified release | 56.685 mg~1000 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| levothyroxine sodium | Tablet | 200 microgram | Current | Unavailable | Unexpected increase in consumer demand | 24/07/2025 |
| ethosuximide | Capsule, soft | 250 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| framycetin sulfate | Eye and Ear Drops | 5 mg/mL | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 24/07/2025 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 24/07/2025 |
| ropivacaine hydrochloride | Injection, solution | 2 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/07/2025 |
| spironolactone | Tablet, film coated | 25 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 24/07/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Anticipated | Available | Commercial Changes / Commercial viability | 24/07/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/07/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Resolved | Available | Manufacturing | 24/07/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Unavailable | Manufacturing | 23/07/2025 |
| tramadol hydrochloride | Tablet, modified release | 200 mg | Anticipated | Available | Manufacturing | 23/07/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Current | Unavailable | Manufacturing | 23/07/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Unavailable | Manufacturing | 23/07/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Unavailable | Manufacturing | 23/07/2025 |
| aripiprazole | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 23/07/2025 |
| tramadol hydrochloride | Tablet, modified release | 200 mg | Resolved | Available | Manufacturing | 23/07/2025 |
| entecavir | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 23/07/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Current | Limited Availability | Manufacturing | 23/07/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 10.341 mg~10 mg | Current | Unavailable | Manufacturing | 23/07/2025 |
| sertraline hydrochloride | Tablet, film coated | 56 mg | Current | Limited Availability | Manufacturing | 23/07/2025 |
| sertraline hydrochloride | Tablet, film coated | 112 mg | Current | Limited Availability | Manufacturing | 23/07/2025 |
| midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 22/07/2025 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 22/07/2025 |
| trimethoprim~sulfamethoxazole | Injection, concentrated | 16 mg/mL~80 mg/mL | Current | Limited Availability | Manufacturing | 22/07/2025 |
| indapamide hemihydrate~perindopril erbumine | Tablet | 1.25 mg~4 mg | Current | Unavailable | Manufacturing | 22/07/2025 |
| Pneumococcal purified capsular polysaccharides | Injection, solution | 50 microgram/mL | Current | Only available under NIP or government programs | Unexpected increase in consumer demand | 22/07/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Manufacturing | 22/07/2025 |
| bleomycin sulfate | Injection, powder for | 15000 IU | Anticipated | Available | Manufacturing | 22/07/2025 |
| dexamethasone~framycetin sulfate~gramicidin | Ear Drops | .5 mg/mL~5 mg/mL~.05 mg/mL | Current | Limited Availability | Manufacturing | 22/07/2025 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 22/07/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 22/07/2025 |
| omega3acid ethyl esters 90 | Capsule, soft | 1000 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 21/07/2025 |
| naloxone hydrochloride dihydrate~buprenorphine hydrochloride | Soluble Film | 2.44 mg~8.64 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 21/07/2025 |
| mycophenolate mofetil | Capsule | 250 mg | Current | Limited Availability | Manufacturing | 21/07/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| finasteride | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 21/07/2025 |
| candesartan cilexetil | Tablet, uncoated | 16 mg | Resolved | Available | Manufacturing | 21/07/2025 |
| ondansetron | Tablet, orally disintegrating | 8 mg | Anticipated | Available | Manufacturing | 21/07/2025 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~12.5 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~12.5 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 25 mg~300 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 21/07/2025 |
| nitisinone | Tablet | 10 mg | Resolved | Available | Manufacturing | 21/07/2025 |
| nitisinone | Tablet | 5 mg | Resolved | Available | Manufacturing | 21/07/2025 |
| olanzapine | Tablet, uncoated | 5 mg | Resolved | Available | Manufacturing | 21/07/2025 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 56.69 mg | Resolved | Available | Manufacturing | 21/07/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 21/07/2025 |
| levothyroxine sodium | Tablet | 75 microgram | Current | Unavailable | Manufacturing | 21/07/2025 |
| heparin sodium | Injection, solution | 5000 IU | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 21/07/2025 |
| tamoxifen citrate | Tablet, uncoated | 30.4 mg | Resolved | Available | Commercial Changes / Commercial viability | 21/07/2025 |
| sirolimus | Oral Liquid, solution | 1 mg/mL | Anticipated | Available | Manufacturing | 21/07/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Anticipated | Available | Manufacturing | 21/07/2025 |
2025年7月28日